Skip to main content

Table 6 Projected time free of complications as estimated using a cohort of IMSS adult patients with T1D

From: Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

  CSII
(years)
MDI
(years)
Absolute difference
(years)
Any complications 1.12 0.73 0.39
Background retinopathy 7.1 4.86 2.24
Proliferative retinopathy 18.74 16.18 2.56
Microalbuminuria 8.09 6.13 1.96
Gross proteinuria 18.89 16.07 2.82
End-stage renal disease 23.75 21.13 2.62
First ulcer 18.3 15.22 3.08
Amputation 22.83 20.19 2.64
Neuropathy 10.43 7.72 2.71
Peripheral vascular disease 23.41 21 2.41
Congestive heart failure 23.97 21.4 2.57
Angina 23.72 21.26 2.46
Myocardial infarction 24.21 21.75 2.46
Stroke 23.77 21.47 2.3
Cataract 21.46 19.54 1.92